Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,851
Total Claims
$890K
Drug Cost
434
Beneficiaries
$2,050
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+45%
Cost per patient vs peers
$2,050 vs $1,411 avg
+99%
Brand preference vs peers
21.1% vs 10.6% avg
Brand vs Generic
Brand: 2,499 claims · $635K
Generic: 9,323 claims · $252K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 653 | $173K |
| Dulaglutide | 60 | $43K |
| Rivaroxaban | 136 | $36K |
| Fluticasone/Vilanterol | 71 | $23K |
| Sitagliptin Phosphate | 110 | $23K |
| Rifaximin | 12 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 140 | $18K |
| Budesonide/Formoterol Fumarate | 47 | $17K |
| Tiotropium Bromide | 43 | $15K |
| Linaclotide | 26 | $14K |
| Empagliflozin | 46 | $13K |
| Linagliptin | 48 | $13K |
| Dapagliflozin Propanediol | 47 | $13K |
| Atorvastatin Calcium | 746 | $12K |
| Cyclosporine | 19 | $12K |
Prescribing Profile
Patient Profile
78
Avg Age
64%
Female
2.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data